Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
ROR1 VHH recombinant monoclonal antibody
ROR2 VHH recombinant monoclonal antibody
RSPO3 VHH recombinant monoclonal antibody
RTN4 VHH recombinant monoclonal antibody
SAA1 VHH recombinant monoclonal antibody
SDC1 VHH recombinant monoclonal antibody
SELP VHH recombinant monoclonal antibody
SEMA4D VHH recombinant monoclonal antibody
SIGLEC8 VHH recombinant monoclonal antibody
SIRPA VHH recombinant monoclonal antibody
SLAMF7 VHH recombinant monoclonal antibody
SLC1A5 VHH recombinant monoclonal antibody